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Introduction
As time goes by, we have almost forgotten the atomic
bombs that fell on Hiroshima and Nagasaki, Japan.
The horror and sorrow of that time seem buried in
the past. However, there remain many atomic bomb
survivors in the world. According to data from the
Radiation Effects Research Foundation (RERF) in
Japan, more than 45% of this population was still 
alive in 2007.1 They have a high risk of cancer and
non-cancer disorders, and must face the possibility of 
radiation-induced cancer and non-cancer disorders
every year. In this report, we present an 81-year-old
woman with malignant lymphoma over T10–11 ver-
tebrae with compression to her spinal cord and follic-
ular lymphoma in the right elbow region diagnosed at
the same time. She had had papillary carcinoma of the
thyroid gland 11 years previously. The details of her
clinical presentation, as well as the incidence and diag-
nosis of radiation-related cancers, will be discussed in
this article.
Case Report
This 81-year-old woman was living in Nagasaki in
1945, when she was 19 years old. She claimed that
she had not had any specific discomfort or any acute
radiation-related disease since 1945 when the atomic
bomb exploded in Nagasaki. The estimated dose of
radiation she had received was <1 rad, because the dis-
tance from her work place to the site of bomb detona-
tion was >2km.2 According to the latest RERF report
in 2007, the incidence of solid cancer at the age of
70, if exposed at the age of 30, increased by about 58%
per Gy for women.1
According to the patient’s statement, she came back
to Taiwan when she was 20 years old. Several decades
later, when she was 65 years old, she began to receive
regular follow-up in the special institute of Japan for
atomic-bomb survivors. The examinations showed no
significant abnormality until she was 70 years old.
Unfortunately, thyroid gland enlargement was found
incidentally by doctors in Taiwan. Fine needle aspiration
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was performed, and pathology showed papillary carci-
noma of the thyroid, for which she underwent tumor
excision. Due to residual tumor embedded in the
great vessels and nerves, radioactive iodine (I131) 
was prescribed. Tumor recurred when the patient was
77 years old. Surgical excision was performed, and a
1.5 × 2 cm nodule lesion was removed. Regular fol-
low-up revealed no tumor recurrence and no distant
metastasis.
However, when the patient was 81 years old, a
firm but movable mass was found on the ulnar side of
her right elbow region. Ultrasound showed a hetero-
geneous hypoechoic mass lesion, 2.9 × 1.7 cm in size,
with hypervascularity (Figure 1). Although the tumor
was attached close to the ulnar nerve, tumor removal
was achieved uneventfully. Pathology showed malig-
nant lymphoma with nearly total effacement of the
nodal architecture by neoplastic follicles made up mainly
of large cleaved cells. Grade 1 follicular lymphoma
with predominantly follicular pattern was diagnosed
(Figure 2).
At the same time, the patient also complained about
back pain, especially at night, of several days’ duration.
Knocking pain was found over the T-spine area, with
radiation to the buttocks and femoral region (T12 to
L3 dermatome). No paresthesia or weakness (muscle
power: 5/5) was found, but deep tendon reflexes of
the left lower limb were mildly increased (+++). Due
to suspicion of tumor, plain X-ray and bone scan were
arranged. Except for degenerative joint change, there
was no specific finding (Figure 3). There were also no
hot spots on bone scan (Figure 4). Although the sen-
sitivity of bone scan is high, we continued to suspect a
spinal tumor because of the patient’s clinical symptoms
and signs. Therefore, thoracolumbar spine magnetic
resonance imaging (MRI) with contrast enhancement
was performed (Figure 5). There was an infiltrative
soft tissue mass in the left paraspinal space of T10–11,
involving the left T11 posterior vertebra, pedicle, neu-
roforamen, epidural space, spinal lamina, spinal process,
and surrounding retrospinal space, encasing the spinal
cord and causing spinal stenosis. The mass measured
about 5.9 × 4.1 × 6.3 cm in size. Moreover, there were
para-aortic enlarged lymph nodes and mild compres-
sion fracture in T11. The radiographic images were
compatible with spinal lymphoma.
Computed tomography-guided biopsy was done and
showed diffuse infiltration of lymphoid cells associated
with prominent germinal centers in a specimen of bone
marrow of T11 vertebrae (Figure 6). The specimen of
Figure 1. Ultrasound of the right arm region shows a heteroge-
neous hypoechoic mass lesion, 2.91 × 1.67 cm, medial aspect
with hypervascularity.
Figure 2. Surgical specimen from right elbow: pathology of grade I follicular lymphoma. (A) Malignant lymphoma with nearly total efface-
ment of the nodal architecture, by (B) neoplastic follicles made up predominantly of large cleaved cells. Mean centroblasts are about
2/high power field.
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paravertebral soft tissue showed only aggregation of
small lymphocytes. The hematoxylin and eosin pat-
tern of the specimen of bone marrow was like that of
the specimen of right elbow lymphoma. Under the diag-
nosis of malignant lymphoma, the patient received 
4-course chemotherapy of R-COP (rituximab, endoxan,
oncovin, prednisolone). Adriamycin was not used due
to its cardiotoxicity.
After 1-year follow-up, the patient’s back pain and
other discomfort had dramatically improved, and she
could walk without any support. MRI revealed obvi-
ous regressive change in the tumor compared to the
previous study.
Discussion
In the latest reports on mortality in the cohort of
atomic bomb survivors followed-up by the RERF in
2003, the relative risks of cancer declined with increas-
ing attained age (age at exposure + time since expo-
sure).3 In other words, those who were children when
exposed have higher relative risks of developing cancer.
A useful representative value of excess relative risk is
given for those exposed at the age of 30—the solid
cancer risk was elevated by 47% per sievert at the age
of 70.4
According to the mortality data of the atomic bomb
survivors in 1950–1985, there was an increase in can-
cers such as leukemia, lung, breast, esophagus, stomach,
colon, ovary, urinary bladder, and multiple myeloma,
but no increase in cancers of the rectum, gallbladder,
pancreas, prostate, uterus, and malignant lymphoma.
Again, sensitivity to radiation was higher among those
who were younger at the time of the bomb explosion
than among those who were older.5
Lymphomas are rarely found in this group of
patients. In 1973, Nishiyama et al reported the preva-
lence of malignant lymphoma in these survivors,2 who
A B
Figure 3. Plain X-ray shows mild osteoporosis and degenerative lumbar spondylosis but no evidence of vertebral bony erosion or other
findings compatible with the patient’s low back pain.
Figure 4. Whole-body bone scan performed 3 hours after intra-
venous injection of 15 mCi of Tc-99m-MDP. No abnormal focal
bony uptake is seen.
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Figure 5. Magnetic resonance imaging of the thoracolumbar spine. Post-contrast sagittal and axial T1-weighted images with fat saturation.
(A) Before chemotherapy: infiltrative soft tissue mass over the left paraspinal space at T10–11, involving the most critical structure 
of left T11. The mass is about 5.9 × 4.1 × 6.3 cm in size, and mild compression fracture is seen in T11. (B) One year later, after
chemotherapy, regressive change is seen.
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Figure 6. Pathology of atypical lymphoid cells from bone marrow of T11 vertebrae (from computed tomography-guided biopsy). The
specimen is composed of: (A) bone fragments and bone marrow tissue with (B) diffuse infiltration of lymphoid cells associated 
with prominent germinal centers. The hematoxylin and eosin pattern of this specimen is like that of the lymphoma specimen from the
right elbow.
were classified by 2 locations (Hiroshima and Nagasaki)
and 3 subgroups (total dose: < 1 rad; 1–99 rad; ≥ 100
rad). Total dose was estimated by the distance from the
hypocenter of the bomb. They found that the preva-
lences of malignant lymphoma were 3.47, 2.48 and
25.49 per 10,000 population in Hiroshima in the 
3 subgroups, respectively. In Nagasaki, the prevalences
were 7.95, 5.88 and 9.44 per 10,000 population in
the 3 subgroups, respectively.2
In 1994, Preston et al presented an analysis of data
on the incidence of lymphoma in the Life Span Study
cohort of atomic bomb survivors during 1950 to
1987. That was the first analysis of the lymphoma
incidence data of the cohort. A total of 229 lym-
phoma cases out of 93,696 survivors were identified.
There was some evidence of increasing risk of lym-
phoma in males (excess absolute risk = 0.6 cases per
104 person-year sievert), but no evidence of any excess
risk in females.6
Awa et al7 and Kamada and Uchino8 reported
chromosome aberrations of T lymphocytes and bone 
marrow cells in atomic bomb survivors. Kamada et al 
also reported on the karyotypically abnormal clone of 
B-lymphocytes in vivo.9 It is important for us to eluci-
date the processes of malignant lymphoma. Although
many of the key mechanisms that explain how radia-
tion induces human cancer (especially years after expo-
sure) have yet to be determined, we now at least
know for certain that radiation exposure indeed leads
to breakage of double-strands in DNA, and causes
defects in the DNA repair process. Extensive research
is being carried out to identify which specific genes
mutate in that repair process. Polygenic effects may
play a role, and various single-nucleotide polymor-
phisms may, in combination, give rise to sufficiently
dysregulated DNA repair, leading to predisposition to
cancers.10 This may well explain why some individuals
who are exposed to radiation only develop single can-
cer, and why other patients develop multiple cancers.
Lyons et al reviewed the diagnosis of epidural malig-
nant lymphoma.11 Plain spine radiographic abnormal-
ities have been reported in 15–42% of cases of spinal
epidural lymphoma.12–15 However, these reports were
published before the advent of computed tomography,
MRI, or other investigations.12,13 In patients with sec-
ondary epidural lymphoma, spine radiographic abnor-
malities are detected in approximately 33% of cases.
There is no report about the sensitivity and speci-
ficity of bone scan in diagnosing epidural lymphoma.
In general, the sensitivity of bone scan is high, while
its specificity is low. In this case, initial radiography
and bone scan did not show any abnormality. If MRI
was not available, diagnosis and treatment would have
been delayed. MRI or positron emission tomography
may be required in atomic-bomb survivors who have
severe back pain. Moreover, life-long regular physical
examinations are needed in such patients.
Mascalchi et al reviewed the MRI findings of spinal
epidural lymphoma in 8 patients.16 The mean longi-
tudinal extension of the epidural lesion was 2.6 vertebral
segments. The tumors were homogeneously isoin-
tense with the spinal cord on T1-weighted images
and isointense or hyperintense on proton-density and
T2-weighted images. Diffuse signal changes in the
vertebral body marrow consistent with osteolytic or
osteoblastic changes were identified adjacent to or at
a distance from the epidural lesion.
Our patient was exposed to radiation when she
was 19 years old, but she was not too close to the site
of bomb explosion. The histology was a rare follicular
lymphoma, in contrast to the predominant types, in-
cluding lymphosarcoma, reticulum cell sarcoma, and
Hodgkin’s disease, in Nishiyama et al’s report.2 In their
report, the mean time to onset of malignant lymphoma
was 12 years after bomb explosion. The 1-year sur-
vival rate was 45–58%, depending on histologic type
(Hodgkin’s disease > lymphosarcoma > reticulum cell
sarcoma). Although we are unable to confirm whether
our patient’s malignant lymphoma was related to
atomic bomb radiation, we did observe her excellent
response to chemotherapy. As time goes by, slowly-
growing malignant follicular lymphomas, like in this
patient, require further study, data collection and analy-
sis as these survivors age. Finally, we suggest that the
diagnosis and management of epidural malignant lym-
phoma should be more careful and aggressive, even if
bone scan results are negative, especially in patients with
a history of radiation exposure.
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